Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Seldin

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
The American Journal of Pathology|January 13, 2011
Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathyMichael J Greene, Flora Sam, Pamela T Soo Hoo, et al.
Arthritis and Rheumatism|October 31, 2007
Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survivalTatiana Prokaeva, Brian Spencer, Maurya Kaut, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 28, 2016
Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients<sup></sup>Janet Shu, Stephen Lo, Margot Phillips, et al.
Kidney International|March 13, 2003
High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal diseaseLiam F Casserly, Amit Fadia, Vaishali Sanchorawala, et al.
Biochemistry|October 13, 2010
The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chainElena S Klimtchuk, Olga Gursky, Rupesh S Patel, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 12, 2010
Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature reviewMartin Tam, David C Seldin, Benjamin M Forbes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 11, 2015
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical TrialVaishali Sanchorawala, Dina Brauneis, Anthony C Shelton, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 10, 2010
Kidney dysfunction during lenalidomide treatment for AL amyloidosisRichard Specter, Vaishali Sanchorawala, David C Seldin, et al.
Hypertension (Dallas, Tex. : 1979)|August 18, 2010
Impaired 3',5'-cyclic adenosine monophosphate-mediated signaling in immediate early responsive gene X-1-deficient vascular smooth muscle cellsMohd Shahid, Li Shen, David C Seldin, et al.
Blood|September 9, 2006
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trialVaishali Sanchorawala, Daniel G Wright, Michael Rosenzweig, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
The American Journal of Pathology|January 13, 2011
Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathyMichael J Greene, Flora Sam, Pamela T Soo Hoo, et al.
Arthritis and Rheumatism|October 31, 2007
Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survivalTatiana Prokaeva, Brian Spencer, Maurya Kaut, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 28, 2016
Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients<sup></sup>Janet Shu, Stephen Lo, Margot Phillips, et al.
Kidney International|March 13, 2003
High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal diseaseLiam F Casserly, Amit Fadia, Vaishali Sanchorawala, et al.
Biochemistry|October 13, 2010
The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chainElena S Klimtchuk, Olga Gursky, Rupesh S Patel, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 12, 2010
Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature reviewMartin Tam, David C Seldin, Benjamin M Forbes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 11, 2015
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical TrialVaishali Sanchorawala, Dina Brauneis, Anthony C Shelton, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 10, 2010
Kidney dysfunction during lenalidomide treatment for AL amyloidosisRichard Specter, Vaishali Sanchorawala, David C Seldin, et al.
Hypertension (Dallas, Tex. : 1979)|August 18, 2010
Impaired 3',5'-cyclic adenosine monophosphate-mediated signaling in immediate early responsive gene X-1-deficient vascular smooth muscle cellsMohd Shahid, Li Shen, David C Seldin, et al.
Blood|September 9, 2006
Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trialVaishali Sanchorawala, Daniel G Wright, Michael Rosenzweig, et al.
Pageof 11